Package 76045-223-30

Brand: glycopyrrolate

Generic: glycopyrrolate
NDC Package

Package Facts

Identity

Package NDC 76045-223-30
Digits Only 7604522330
Product NDC 76045-223
Description

10 SYRINGE in 1 CARTON (76045-223-30) / 3 mL in 1 SYRINGE (76045-223-03)

Marketing

Marketing Status
Marketed Since 2022-04-21
Brand glycopyrrolate
Generic glycopyrrolate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "1925138e-94b7-4e29-815e-f6681943a734", "openfda": {"unii": ["V92SO9WP2I"], "rxcui": ["2473383"], "spl_set_id": ["685aaf64-1a64-42f9-a96f-4764d650c26f"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 SYRINGE in 1 CARTON (76045-223-30)  / 3 mL in 1 SYRINGE (76045-223-03)", "package_ndc": "76045-223-30", "marketing_start_date": "20220421"}], "brand_name": "Glycopyrrolate", "product_id": "76045-223_1925138e-94b7-4e29-815e-f6681943a734", "dosage_form": "INJECTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "76045-223", "generic_name": "Glycopyrrolate", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glycopyrrolate", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "NDA214919", "marketing_category": "NDA", "marketing_start_date": "20220421", "listing_expiration_date": "20261231"}